JP2023552864A5 - - Google Patents
Info
- Publication number
- JP2023552864A5 JP2023552864A5 JP2023535832A JP2023535832A JP2023552864A5 JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5 JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2019702.6A GB202019702D0 (en) | 2020-12-14 | 2020-12-14 | Therapeutic agents |
| GB2019702.6 | 2020-12-14 | ||
| GBGB2109583.1A GB202109583D0 (en) | 2021-07-02 | 2021-07-02 | Therapeutic agents |
| GB2109583.1 | 2021-07-02 | ||
| PCT/EP2021/084448 WO2022128584A1 (en) | 2020-12-14 | 2021-12-06 | Imidazopyridazine derivatives as il-17 modulators |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023552864A JP2023552864A (ja) | 2023-12-19 |
| JPWO2022128584A5 JPWO2022128584A5 (https=) | 2024-11-15 |
| JP2023552864A5 true JP2023552864A5 (https=) | 2024-11-15 |
| JP7827725B2 JP7827725B2 (ja) | 2026-03-10 |
Family
ID=79164779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535832A Active JP7827725B2 (ja) | 2020-12-14 | 2021-12-06 | Ｉｌ－１７モジュレータとしてのイミダゾピリダジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240140951A1 (https=) |
| EP (1) | EP4259631A1 (https=) |
| JP (1) | JP7827725B2 (https=) |
| CA (1) | CA3200594A1 (https=) |
| WO (1) | WO2022128584A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| CA3200594A1 (en) * | 2020-12-14 | 2022-06-23 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| CN121487927A (zh) * | 2023-03-14 | 2026-02-06 | 歌礼制药(中国)有限公司 | Il-17a的小分子调节剂、制备方法及其使用方法 |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9309313B2 (en) | 2008-01-09 | 2016-04-12 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of ocular inflammatory disorders |
| US9284283B2 (en) | 2012-02-02 | 2016-03-15 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating IL-17 |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| GB201709456D0 (en) | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2019138017A1 (en) | 2018-01-15 | 2019-07-18 | Ucb Biopharma Sprl | Fused imidazole derivatives as il-17 modulators |
| WO2019223718A1 (zh) | 2018-05-22 | 2019-11-28 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| JP7349491B2 (ja) | 2018-07-12 | 2023-09-22 | ユーシービー バイオファルマ エスアールエル | Ｉｌ－１７モジュレーターとしてのスピロ環状インダン類似体 |
| GB201820166D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201820165D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| BR112021010453A2 (pt) | 2018-12-19 | 2021-08-24 | Leo Pharma A/S | Composto, e, composição farmacêutica |
| TWI752400B (zh) | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| US20220162191A1 (en) | 2019-03-08 | 2022-05-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB201909191D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909194D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| KR20230019507A (ko) | 2020-04-30 | 2023-02-08 | 얀센 파마슈티카 엔.브이. | Il-17의 조절제로서의 이미다조피리다진 |
| MX2022013649A (es) | 2020-04-30 | 2023-02-01 | Janssen Pharmaceutica Nv | Métodos para identificar moduladores de la ruta de il-17. |
| CA3200594A1 (en) * | 2020-12-14 | 2022-06-23 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
-
2021
- 2021-12-06 CA CA3200594A patent/CA3200594A1/en active Pending
- 2021-12-06 WO PCT/EP2021/084448 patent/WO2022128584A1/en not_active Ceased
- 2021-12-06 JP JP2023535832A patent/JP7827725B2/ja active Active
- 2021-12-06 US US18/267,235 patent/US20240140951A1/en active Pending
- 2021-12-06 EP EP21834749.0A patent/EP4259631A1/en active Pending